Loading...
Trading.HK
Global Markets
T.HK
News Markets

Menu

Home
Asia
Hong Kong China Japan India Singapore Taiwan
Americas
US Canada Brazil Mexico
Europe & Others
UK Germany France Australia
View All Markets →
Traditional Assets
Equities Options ETFs Bonds
Alternative Assets
Cryptocurrency Forex Commodities Macro Indicators
News
Market Analysis
Correlation Matrix Risk-Return Profile Market Sentiment Momentum Signals
View All Analytics →
Screener Compare Search Market Status
/ News / Markets

News

All News
By Category
Central Banks Commodities Corporate Corporate Actions Crypto Cryptocurrency Dividends Earnings Economic Data Forex IPOs Insider Trading Legal M&A Macro Market Update Markets Ratings Regulations Technology
Coverage
Methodology
FAQ

Trump Slashes Weight-Loss Drug Prices By Up To 74% In Deal With Lilly, Novo

Published 3 days ago • Nov 6, 2025 at 5:55 PM • Neutral
Trump Slashes Weight-Loss Drug Prices By Up To 74% In Deal With Lilly, Novo

Related Stocks

N1VO34.SA Novo Nordisk A/... NOVO-B.CO Novo Nordisk A/...
The Trump administration announced deals Thursday with Eli Lilly and Novo Nordisk to slash the prices of their weight-loss drugs.

Continue Reading

View Comments

More News

Anmodning om ophør af suspension i enkelt afdeling under Investeringsforeningen Danske Invest

46 minutes ago Neutral

BOJ summary indicates chances of December interest rate hike

1 hour ago Positive

Why James Hardie Industries (ASX:JHX) Is Down 18.9% After Surge in Class Action Lawsuits and Sales Disclosure

1 hour ago Neutral

Transaction in Own Shares

1 hour ago Neutral

Sir Dave Lewis Appointed Diageo plc CEO

1 hour ago Positive

Trading.HK

Your comprehensive platform for global financial markets data, analytics, and insights.

Markets

  • Asia Pacific
  • Americas
  • Europe
  • Market Status

Asset Classes

  • Equities
  • Cryptocurrency
  • ETFs
  • Forex
  • Commodities

Resources

  • Market News
  • Analytics
  • Stock Screener
  • Compare Stocks
  • Methodology
  • Coverage
  • FAQ

© 2025 Trading.HK. All rights reserved.

Privacy Policy Terms of Service Contact